Jungnelius U - Search Results

1

Dacarbazine-vindesine versus dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A randomised phase III trial.

Jungnelius U, Ringborg U, Aamdal S, Mattsson J, Stierner U, Ingvar C, Malmström P, Andersson R, Karlsson M, Willman K, Wist E, Bjelkengren G, Westberg R. Jungnelius U, et al. Eur J Cancer. 1998 Aug;34(9):1368-74. doi: 10.1016/s0959-8049(98)00068-9. Eur J Cancer. 1998. PMID: 9849419 Clinical Trial.

2

Dacarbazine-vindesine-cisplatin in disseminated malignant melanoma. A phase I-II trial.

Ringborg U, Jungnelius U, Hansson J, Strander H. Ringborg U, et al. Among authors: jungnelius u. Am J Clin Oncol. 1990 Jun;13(3):214-7. doi: 10.1097/00000421-199006000-00007. Am J Clin Oncol. 1990. PMID: 2346126

3

Correlation of DNA ploidy and S-phase fraction with chemotherapeutic response and survival in a randomized study of disseminated malignant melanoma.

Karlsson M, Jungnelius U, Aamdal S, Boeryd B, Carstensen J, Kågedal B, Westberg R, Wingren S. Karlsson M, et al. Among authors: jungnelius u. Int J Cancer. 1996 Jan 3;65(1):1-5. doi: 10.1002/(SICI)1097-0215(19960103)65:1<1::AID-IJC1>3.0.CO;2-6. Int J Cancer. 1996. PMID: 8543385 Clinical Trial.

4

Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid.

Hansson J, Berhane K, Castro VM, Jungnelius U, Mannervik B, Ringborg U. Hansson J, et al. Among authors: jungnelius u. Cancer Res. 1991 Jan 1;51(1):94-8. Cancer Res. 1991. PMID: 1988111

5

Melphalan-induced DNA cross-linking and inhibition of DNA and RNA synthesis in human melanoma and lymphoblast cells.

Ringborg U, Hansson J, Jungnelius U, Lewensohn R, Skog S. Ringborg U, et al. Among authors: jungnelius u. Anticancer Res. 1990 Mar-Apr;10(2A):297-301. Anticancer Res. 1990. PMID: 2346304

6

Glutathione transferase P1-1 expression in human melanoma metastases: correlation to N-RAS mutations and expression.

Platz A, Jungnelius U, Grafström E, Lagerlöf B, Mannervik B, Ringborg U. Platz A, et al. Among authors: jungnelius u. Acta Oncol. 1995;34(6):759-65. doi: 10.3109/02841869509127183. Acta Oncol. 1995. PMID: 7576742

7

Cell cycle dependent sensitivity of human melanoma cells to melphalan is correlated with the activity and cellular concentration of glutathione transferases.

Jungnelius U, Hao XY, Skog S, Castro VM, Mannervik B, Ringborg U. Jungnelius U, et al. Carcinogenesis. 1994 Jan;15(1):99-103. doi: 10.1093/carcin/15.1.99. Carcinogenesis. 1994. PMID: 8293555

8

Jungnelius U, Ridderström M, Hansson J, Ringborg U, Mannervik B. Jungnelius U, et al. Biochem Pharmacol. 1994 May 18;47(10):1777-80. doi: 10.1016/0006-2952(94)90305-0. Biochem Pharmacol. 1994. PMID: 8204094

9

High-dose cisplatin treatment: hearing loss and plasma concentrations.

Laurell G, Jungnelius U. Laurell G, et al. Among authors: jungnelius u. Laryngoscope. 1990 Jul;100(7):724-34. doi: 10.1288/00005537-199007000-00008. Laryngoscope. 1990. PMID: 2362532

10

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial.

Petrylak DP, Vogelzang NJ, Budnik N, Wiechno PJ, Sternberg CN, Doner K, Bellmunt J, Burke JM, de Olza MO, Choudhury A, Gschwend JE, Kopyltsov E, Flechon A, Van As N, Houede N, Barton D, Fandi A, Jungnelius U, Li S, de Wit R, Fizazi K. Petrylak DP, et al. Among authors: jungnelius u. Lancet Oncol. 2015 Apr;16(4):417-25. doi: 10.1016/S1470-2045(15)70025-2. Epub 2015 Mar 3. Lancet Oncol. 2015. PMID: 25743937 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters